WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Struggling to focus? Stop multitasking and try the 'pull method' insteadIrish interest in NFL heats up as league scouts more international cities to stage gamesBMX racing world championships hit South Carolina with Olympic berths on the lineHow Jeremy Clarkson, 64, won the title of the UK and Ireland's sexiest manHow Jeremy Clarkson, 64, won the title of the UK and Ireland's sexiest manChina unveils plan to galvanize NEV uptake in rural areasArkansas Supreme Court upholds 2021 voting restrictions that state judge found unconstitutionalHouse votes to require delivery of bombs to Israel, rebuking BidenWatchdog: EPA's lead pipe fix sent about $3 billion to states based on unverified dataFrancis Ford Coppola debuts 'Megalopolis' in Cannes, and the reviews are in
3.0231s , 6496.6484375 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Stellar Stories news portal